Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
79.5M
-
Number of holders
-
169
-
Total 13F shares, excl. options
-
73.8M
-
Shares change
-
+328K
-
Total reported value, excl. options
-
$2.96B
-
Value change
-
+$12.6M
-
Put/Call ratio
-
1.65
-
Number of buys
-
76
-
Number of sells
-
-83
-
Price
-
$40.06
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q2 2022
196 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q2 2022.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 169 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73.8M shares
of 79.5M outstanding shares and own 92.92% of the company stock.
Largest 10 shareholders include FMR LLC (10.7M shares), VANGUARD GROUP INC (7.18M shares), WELLINGTON MANAGEMENT GROUP LLP (7.03M shares), BlackRock Inc. (5.97M shares), RTW INVESTMENTS, LP (5.05M shares), FRANKLIN RESOURCES INC (4.91M shares), STATE STREET CORP (3.62M shares), ARMISTICE CAPITAL, LLC (3.3M shares), Camber Capital Management LP (2.45M shares), and JANUS HENDERSON GROUP PLC (2.14M shares).
This table shows the top 169 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.